B. Heilig

600 total citations
24 papers, 488 citations indexed

About

B. Heilig is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Rheumatology. According to data from OpenAlex, B. Heilig has authored 24 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Immunology and 5 papers in Rheumatology. Recurrent topics in B. Heilig's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cell Adhesion Molecules Research (3 papers). B. Heilig is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cell Adhesion Molecules Research (3 papers). B. Heilig collaborates with scholars based in Germany, Switzerland and Netherlands. B. Heilig's co-authors include Antonio Pezzutto, M. Hüfner, Kirstin Stricker, Klaus‐Michael Debatin, PH Krammer, Astrid Eder, Michael Wermann, Harald Bauer, Michael Schwarz-Eywill and Christoph Fiehn and has published in prestigious journals such as Blood, International Journal of Cancer and Annals of the Rheumatic Diseases.

In The Last Decade

B. Heilig

23 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Heilig Germany 10 197 144 126 110 71 24 488
S. Yoon Choo United States 12 518 2.6× 103 0.7× 166 1.3× 124 1.1× 59 0.8× 24 805
Harold H. Handley United States 14 179 0.9× 221 1.5× 91 0.7× 53 0.5× 30 0.4× 22 560
L. Matarán Spain 13 272 1.4× 142 1.0× 252 2.0× 69 0.6× 33 0.5× 17 551
Hervé Betuel France 12 299 1.5× 206 1.4× 40 0.3× 48 0.4× 189 2.7× 23 764
P Rebello United Kingdom 12 274 1.4× 73 0.5× 39 0.3× 133 1.2× 42 0.6× 19 550
A. Lamour France 16 308 1.6× 118 0.8× 257 2.0× 66 0.6× 31 0.4× 31 642
Maarten J. van Tol Netherlands 11 255 1.3× 110 0.8× 81 0.6× 81 0.7× 180 2.5× 17 571
L Napolitano Italy 9 527 2.7× 124 0.9× 102 0.8× 65 0.6× 54 0.8× 49 834
Shuji Ohta Japan 12 147 0.7× 115 0.8× 221 1.8× 92 0.8× 160 2.3× 24 586
Joshua Levy United States 9 198 1.0× 82 0.6× 142 1.1× 43 0.4× 157 2.2× 14 577

Countries citing papers authored by B. Heilig

Since Specialization
Citations

This map shows the geographic impact of B. Heilig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Heilig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Heilig more than expected).

Fields of papers citing papers by B. Heilig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Heilig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Heilig. The network helps show where B. Heilig may publish in the future.

Co-authorship network of co-authors of B. Heilig

This figure shows the co-authorship network connecting the top 25 collaborators of B. Heilig. A scholar is included among the top collaborators of B. Heilig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Heilig. B. Heilig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
4.
Klußmann, Jens Peter, Orlando Guntinas‐Lichius, B. Heilig, et al.. (1999). Sjögren-Syndrom und beidseitiges MALT-Lymphom der Glandula parotis. HNO. 47(7). 637–641. 1 indexed citations
5.
Bohlen, Heribert, et al.. (1998). Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patientes with rheumatoid arthritis. Zeitschrift für Rheumatologie. 57(2). 95–100. 15 indexed citations
6.
Fiehn, Christoph, Otto Prümmer, H. Gallati, B. Heilig, & W. Hunstein. (1995). Treatment of systemic mastocytosis with interferon‐γ: failure after appearance of anti‐IFN‐γ antibodies. European Journal of Clinical Investigation. 25(8). 615–618. 19 indexed citations
7.
Debatin, Klaus‐Michael, et al.. (1995). Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood. 85(6). 1562–1569. 129 indexed citations
8.
Mapara, Markus Y., Ralf C. Bargou, Christian Beck, et al.. (1994). Lymphotoxin‐α/β heterodimer is expressed on leukemic hairy cells and activated human B lymphocytes. International Journal of Cancer. 58(2). 248–253. 6 indexed citations
9.
Arnold, Jayantha, B. Heilig, B. Kallinowski, et al.. (1994). Soluble tumor necrosis factor receptors in patients with recurrent hepatitis C virus infection after liver transplantation. Journal of Molecular Medicine. 72(6). 470–470. 3 indexed citations
10.
Heilig, B., Antonio Pezzutto, M. Lukoschek, & W. Hunstein. (1994). [Expression of TNF receptors in rheumatoid arthritis and ankylosing spondylitis].. PubMed. 52(6). 383–9. 1 indexed citations
11.
Heilig, B., et al.. (1993). Cytomegalovirus-induced severe thrombocytopenia after liver transplantation.. PubMed. 56(5). 1286–8. 6 indexed citations
12.
Heilig, B., Michael Wermann, H. Gallati, et al.. (1992). Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Journal of Molecular Medicine. 70(1). 22–27. 52 indexed citations
13.
Heilig, B., Markus Y. Mapara, Ralf C. Bargou, Christoph Fiehn, & Bernd Dörken. (1992). TNFα therapy activates human B-lymphoma cells in vivo and may protect myelopoiesis. Leukemia Research. 16(8). 769–773. 1 indexed citations
14.
Wermann, Michael, et al.. (1992). Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis?. Journal of Molecular Medicine. 70(2). 122–4. 4 indexed citations
15.
Schwarz-Eywill, Michael, B. Heilig, Harald Bauer, A Breitbart, & Antonio Pezzutto. (1992). Evaluation of serum ferritin as a marker for adult Still's disease activity.. Annals of the Rheumatic Diseases. 51(5). 683–685. 79 indexed citations
16.
Kraus, T., Arianeb Mehrabi, Jayantha Arnold, et al.. (1992). Evaluation of soluble tumor necrosis factor receptors after orthotopic liver transplantation.. PubMed. 24(6). 2539–41. 7 indexed citations
17.
Schulz, R. J., et al.. (1989). Evidence for immunological differences between circulating and thyroid tissue‐derived thyroglobulin in men. European Journal of Clinical Investigation. 19(5). 459–463. 36 indexed citations
18.
Hüfner, M., et al.. (1988). Comparative plasma thyroglobulin measurements with three non-cross-reactive monoclonal antibodies in metastatic thyroid cancer patients. European Journal of Endocrinology. 118(4). 528–532. 7 indexed citations
19.
Heilig, B., et al.. (1988). Surveillance of diagnostic and treatment measures in Bavaria, 1974–1976. Tubercle. 69(4). 255–265. 1 indexed citations
20.
Heilig, B., M. Hüfner, Bernd Dörken, & H. Schmidt‐Gayk. (1986). Increased heterogeneity of serum thyroglobulin in thyroid cancer patients as determined by monoclonal antibodies. Journal of Molecular Medicine. 64(17). 776–780. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026